Use of immunologic markers in obscure hematologic disease

C. H. Miller, Surinder K Mann, J. Hamersley, F. J. Glassy, L. F. O'Grady

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Tumor cells from two patients with very different clinical diseases were evaluated using immunologic techniques. The first patient had a persistent T-cell lymphocytosis and other symptoms suggestive of T-cell malignancy. She also had an adnexal mass. Following surgical excision, the mass was identified as a benign teratoma that contained thymic tissue. The T-cell lymphocytosis subsided following removal of the mass. The second patient had leukemia, the cells of which were morphologically identified as myelomonocytic. Surface marker studies, however, showed the presence of monoclonal surface immunoglobulins. Enzymatic digestion of the cells showed that the antibodies were cytophilic and not produced by the tumor population. These studies emphasize the value of immunologic techniques in characterizing tumor cells.

Original languageEnglish (US)
Pages (from-to)475-479
Number of pages5
JournalWestern Journal of Medicine
Issue number4
StatePublished - 1983

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Use of immunologic markers in obscure hematologic disease'. Together they form a unique fingerprint.

Cite this